A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients
Public ClinicalTrials.gov record NCT00002322. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Placebo-Controlled Comparative Dose-Response Study of Two Doses of Atevirdine Mesylate (U-87201E) in Combination With Fixed Doses of Zidovudine (AZT) in HIV+ Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the tolerance and antiviral response of two different doses of atevirdine mesylate (U-87201E) in symptomatic HIV-positive patients with CD4 counts of 50-350 cells/mm3, who also take zidovudine (AZT).
Study identification
- NCT ID
- NCT00002322
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Los Angeles County / Health Research Assoc / Drew Med Ctr | Los Angeles | California | 90033 | — |
| UCI Med Ctr | Orange | California | 92668 | — |
| Davies Med Ctr | San Francisco | California | 94114 | — |
| Infectious Disease Research Institute Inc | Tampa | Florida | 33614 | — |
| Johns Hopkins Hosp | Baltimore | Maryland | 212052196 | — |
| Boston City Hosp / FGH-1 | Boston | Massachusetts | 02118 | — |
| East Orange Veterans Administration Med Ctr | East Orange | New Jersey | 07018 | — |
| Buckley Braffman Stern Med Associates | Philadelphia | Pennsylvania | 19107 | — |
| Mem Hosp of Rhode Island | Pawtucket | Rhode Island | 02860 | — |
| Park Plaza Hosp | Houston | Texas | 77004 | — |
| Univ TX San Antonio Health Science Ctr | San Antonio | Texas | 78284 | — |
| Wisconsin Community - Based Research Consortium | Milwaukee | Wisconsin | 53202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002322, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002322 live on ClinicalTrials.gov.